Value
8.9/10data confidence 83%| Component | Sub-score |
|---|---|
| P/E | 8.0 |
| P/S | 9.8 |
| Fwd P/E | 9.2 |
| PEG | 10.0 |
| Analyst target | 7.5 |
- ▸Forward P/E: 10.6x
- ▸PEG: 0.20
- ▸Attractively valued
BZ · Why this verdict
Why KANZHUN LIMITED - American Depo (BZ) is rated BUY WAIT
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictBUY WAIT
Overall score7.2/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
KANZHUN is an exceptional-quality business — free cash flow exceeds net income by 20%, the Rule of 40 registers at 56, and the Piotroski financial health score is a perfect 9 out of 9 — trading at roughly 10x forward earnings with a PEG of 0.18 and approximately 35% upside to the analyst-derived price target. The primary risk is a confirmed technical downtrend below the 200-day moving average, but the roughly 5-to-1 favorable risk/reward makes the discount compelling for investors who can tolerate the near-term technical headwind.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The business converts net income into free cash flow at 120%, earns a perfect Piotroski financial health score of 9 out of 9, carries gross margins of 40%, and passes the Rule of 40 at 56 — placing it among the highest-quality franchises by fundamental measures. Quality breakdown | Free cash flow conversion remains above 100% of net income and the Rule of 40 score stays above 40 over the next 4 quarters, confirming the quality profile is durable. | →Stable |
| CounterHigh cash conversion and margins can reflect a structural market-position advantage that may be difficult to sustain; if revenue growth slows, the Rule of 40 score could fall rapidly as incremental investment absorbs the margin cushion. | ||
At roughly 10x forward earnings with a PEG of 0.18 and 35% headroom to the analyst-derived price target, the stock offers approximately 5-to-1 upside versus downside — a setup that meets the bar for favorable asymmetry. Price targets | The share price closes the gap toward the $19.17 price target within 12 months as the discount to fundamental value narrows. | ↓Deteriorating |
| CounterAnalysts diverge materially on the price target — the noted disagreement at roughly 1.9x the consensus range signals high uncertainty — and the technical downtrend could keep the discount wide for longer than fundamental analysis would suggest. | ||
The company has beaten analyst estimates in 3 of the last 4 quarters — including the most recent print — with the only exception being an essentially in-line result, and the average quarterly surprise runs near 5%. Earnings | The August earnings event comes in at or above estimates, extending the pattern of meeting or exceeding expectations. | →Stable |
| CounterAverage quarterly surprises near 5% are not large enough to act as a strong re-rating catalyst; a miss in the next print would reset sentiment in an already technically challenged setup and could accelerate the downtrend. | ||
The stock trades below the 200-day moving average with the average itself declining at roughly 5% per month, creating a confirmed near-term technical headwind that may delay the price from recovering toward fair value. Momentum breakdown | The price reclaims and holds above the 200-day moving average for at least 3 consecutive sessions, confirming a trend reversal. | →Stable |
| CounterMACD is improving and RSI sits near 61 — the downtrend is present but not accelerating — and rising OBV shows underlying volume accumulation; the technical weakness may reflect a temporary pullback within a longer-term recovery rather than a structural decline. | ||
The business converts net income into free cash flow at 120%, earns a perfect Piotroski financial health score of 9 out of 9, carries gross margins of 40%, and passes the Rule of 40 at 56 — placing it among the highest-quality franchises by fundamental measures.
→StableQuality breakdown
- Expectation
- Free cash flow conversion remains above 100% of net income and the Rule of 40 score stays above 40 over the next 4 quarters, confirming the quality profile is durable.
CounterHigh cash conversion and margins can reflect a structural market-position advantage that may be difficult to sustain; if revenue growth slows, the Rule of 40 score could fall rapidly as incremental investment absorbs the margin cushion.
At roughly 10x forward earnings with a PEG of 0.18 and 35% headroom to the analyst-derived price target, the stock offers approximately 5-to-1 upside versus downside — a setup that meets the bar for favorable asymmetry.
↓DeterioratingPrice targets
- Expectation
- The share price closes the gap toward the $19.17 price target within 12 months as the discount to fundamental value narrows.
CounterAnalysts diverge materially on the price target — the noted disagreement at roughly 1.9x the consensus range signals high uncertainty — and the technical downtrend could keep the discount wide for longer than fundamental analysis would suggest.
The company has beaten analyst estimates in 3 of the last 4 quarters — including the most recent print — with the only exception being an essentially in-line result, and the average quarterly surprise runs near 5%.
→StableEarnings
- Expectation
- The August earnings event comes in at or above estimates, extending the pattern of meeting or exceeding expectations.
CounterAverage quarterly surprises near 5% are not large enough to act as a strong re-rating catalyst; a miss in the next print would reset sentiment in an already technically challenged setup and could accelerate the downtrend.
The stock trades below the 200-day moving average with the average itself declining at roughly 5% per month, creating a confirmed near-term technical headwind that may delay the price from recovering toward fair value.
→StableMomentum breakdown
- Expectation
- The price reclaims and holds above the 200-day moving average for at least 3 consecutive sessions, confirming a trend reversal.
CounterMACD is improving and RSI sits near 61 — the downtrend is present but not accelerating — and rising OBV shows underlying volume accumulation; the technical weakness may reflect a temporary pullback within a longer-term recovery rather than a structural decline.
Per-dimension breakdown
Quality
8.6/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 6.1 |
| ROA | 5.1 |
| Gross margin | 10.0 |
| Op margin | 10.0 |
| Net margin | 10.0 |
| Current ratio | 8.7 |
| FCF quality | 9.0 |
| Moat | 7.8 |
| Rule of 40 | 9.0 |
| Piotroski F | 10.0 |
- ▸Strong margins: 40%
- ▸Excellent cash conversion: 120% FCF/NI
- ▸Wide economic moat
- ▸Compounder quality: strong returns + growth
Growth
7.2/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 4.4 |
| EPS growth | 10.0 |
Momentum
6.2/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 2.8 |
| MACD | 9.7 |
| OBV | 10.0 |
| MA position | 6.0 |
| Volume | 2.7 |
- ▸Overbought bear rally (RSI 73)
- ▸Volume accumulation (rising OBV)
- ▸Below 200-MA, MA slope -7.8%/30d — confirmed downtrend
Sentiment
7.9/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 9.0 |
| Price target | 9.0 |
| erm sentiment | 5.0 |
- ▸Analyst upside: 36%
Insider
6.3/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 6.8 |
| notable moves | 7.0 |
- ▸No net insider activity — $0 (0.000% of mkt cap)
Peer rank
7.2/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 6.6 |
| quality rank | 8.1 |
| growth rank | 4.7 |
- ▸Best-in-class margins
- ▸Conservative debt levels
Technical
2.1/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 2.3 |
| support resistance | 1.9 |
| 52w position | 2.2 |
Risk (lower is worse)
6.8/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 7.5 |
| days to cover | 5.6 |
| volatility | 3.3 |
| put call | 10.0 |
| implied vol | 1.2 |
| beta | 10.0 |
| debt equity | 10.0 |
- ▸High IV: 73%
Catalyst
6.5/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 5.0 |
| dividend safety | 7.5 |
- ▸Strong earnings: 3B/0M
- ▸Dividend aristocrat: 1.1% yield
How the verdict was assembled
Engine trigger
Quality-value play. Wait for momentum improvement.
Engine technical detail
verdict_path:
L4:PATH_C_QUALITY_VALUE_WAIT|ENTRY_STICKY:PRIOR_STILL_VIABLEPassed (9)
- MOMENTUM:6.2>=5.5
- ASYMMETRY:1.5>=1.5
- INSIDER:OK
- DEATH_CROSS:QUALITY_MOMENTUM_EXEMPT
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:26d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (0)
none
Warning (1)
- DEATH_CROSS:quality=8.6>=7.5+momentum=6.2>=5.0 exempted
Reward-to-Risk
1.50
Upside
+22.5%
Downside
15.0%
Sizing output
STARTER
SetupRecovery — Death cross but MACD improving, RSI 73
EdgeCatalyst-Driven — Earnings in 26d with 3/4 beat streak
SuitabilityModerate — Balanced profile
Investment implication
The C-path quality+value combination triggered the STRONG_BUY_WAIT verdict: quality 8.6 and value 8.9 both clear their thresholds, with asymmetric R:R of 1.50 supporting the read.
The strongest dimensions are Value at 8.9, Quality at 8.6, and Sentiment at 7.9; the weakest are Technical at 2.1, Momentum at 6.2, and Insider at 6.3. The V9 engine cleared all gates with 1 warning, producing an asymmetric reward-to-risk of 1.50 and an engine sizing output of STARTER.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Exceptional Cash Generating Quality
Trip ifRule of 40 score falls below 40 for 2 consecutive reporting periods, eliminating the growth-quality premium underpinning the franchise thesis.
- P2Asymmetric Valuation Opportunity
Trip ifRevenue growth rate falls below 10% YoY for 2 consecutive quarters, materially reducing the growth premium embedded in the PEG of 0.18.
- P3Earnings Delivery Track Record
Trip ifEPS surprise falls below 0% for 2 consecutive quarters.
- P4Technical Downtrend Headwind
Trip ifPrice reclaims and holds above the 200-day moving average for 3 consecutive sessions, confirming the downtrend has reversed.